Oncotarget is a top online weekly journal which publishes information on oncology. They review the work of professional field researchers and come up with a well round topic on the findings concerning about a particular aging and cancer-related diseases. Oncotarget online site publisher was established in 2010 by the famous journal publishers, the Impact. The journal provides insights and information on diseases. Moreover, they offer definitions of health terminologies and description of certain diseases affecting human race and how they can be treated. The journal also provides its users with the opportunity to know whatever is trending in the healthcare field and the discoveries that have been made concerning the treatment of oncology disorders. Furthermore, Oncotarget has proven to be an encouragement to talented young researchers who are practicing medicine.
Any discovery made on a weekly basis is reviewed by the team of qualified and credited editors who make sure the paper meets the standard needed and release it to the public. The information in Oncotarget site can be accessed freely without any charges. The journal has earned reputation across the globe for its easy accessibility and for providing remedies to cancer patients and age-related diseases.Oncotarget provides information on how particular treatment approaches have been employed and the positive impact they have caused to the patients. It provides the recommendation on the already existing therapies as well as the new methods in the market around the world about disease treatment.
What makes Oncotarget more unique is how the teamwork make sure the paper meets the merit. Therefore, any information found on Oncotarget website should be taken seriously and be of use to any person.They have supported scientific discoveries not only in oncology but also in other fields. Currently, Oncotarget is accepting articles and projects from various discipline alongside oncology. They have expanded their scope of operations, and they are taking in reports from pharmacology, body metabolism, cardiology, neuroscience, cell biology and endocrinology among others. Each article passes through the editorial team which is supervised by the senior and chief editor Mr. Mikhail Blagosklonny and also Mr. V. Gudkov before it goes to the public domain.